FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS
For citations:
FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS. Pediatric pharmacology. 2024;21(4):385. (In Russ.)
Views:
802
JATS XML
Email this article 